Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
7,057 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
Schrappe M, Locatelli F, Valsecchi MG, Zugmaier G, Vossen-Gajcy M, Starý J, Attarbaschi A, Möricke A, Bourquin JP, Barbaric D, Elitzur S, Silvestri D, Kolenova A, Dalla-Pozza L, Bodmer N, Stanulla M, Alten J, Zaman F, Bergmann A, Cazzaniga G, Brüggemann M, Buldini B, Köhler R, Fazio G, Rössig C, Sramkova L, Parasole R, Hundsdörfer P, Putti MC, Borkhardt A, Fagioli F, Bettini LR, Poyer F, von Stackelberg A, Vinti L, Conter V, Zimmermann M, Rizzari C, Cario G, Biondi A, AIEOP-BFM ALL 2017 Consortium. · N Engl J Med · 2026 · cited 1 timesclinical trial, phase iii, multicenter study
- Ex Vivo Thrombin Generation Assessment of Four Anticoagulants in Children with Acute Lymphoblastic Leukemia.
Leader A, Wolach O, Gavrieli B, Elitzur S, Spronk HMH, Nagy M, van Oerle R, Spectre G, Shimony S, Moshe Y, Mahajna R, Martin L, Gilad G, Gilead O, Avrahami G, Izraeli S, Raanani P, Barzilai-Birenboim S. · Pediatr Hematol Oncol · 2026 · cited 0 timesclinical trial
- Carfilzomib plus induction chemotherapy for children with relapsed or refractory acute lymphoblastic leukemia.
Locatelli F, Karakukcu M, Huynh V, González-Martínez B, Lins MM, Lu MY, Sulis ML, Pauly M, Morris C, Braunlin M, Talpes M, Gore L. · Blood Adv · 2026 · cited 0 timesOpen accessclinical trial, phase ii
- Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia.
Gong X, Liu Y, Fang Q, Gu R, Liu K, Lin D, Zhou C, Zhang G, Gong B, Wei S, Li Y, Li S, Wang Y, Qiu S, Liu B, Wang Y, Mi Y, Wei H, Wang J. · Blood · 2026 · cited 1 timesclinical trial, phase ii
- Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis.
Lv W, Li D, Li J, Xie Y, Yang X. · Clin Invest Med · 2026 · cited 0 timesmeta-analysis, systematic review
- Pediatric-inspired regimens and HSCT for adolescents and young adults with acute lymphoblastic leukemia.
Sereda Y, Mai HJ, Kanaan G, Melson JW, Terasawa T, Cheung MC, Stock W, Wolfson JA, Saldanha IJ, Balk EM. · Blood Adv · 2026 · cited 1 timesOpen accessmeta-analysis, review-article
- Bicistronic CD19/CD22 CAR T-Cell Therapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.
Wan X, Tang Y, Cai J, Song L, Wang T, Li W, Yang L, Wang X, Luo C, Zhu H, An K, Su M, Zhang J, Yang J, Shi W, Fei C, Shen W, Jia R, Yang X, Tang J, Wu J, Gu J, Mo J, Huang J, Li Y, Zhou G, Ding L, Liang J, Wang J, Zhou Z, Wang X, Cao Q, Zhang J, Ren H, Qian J, Xiao P, He H, Jiang H, Hu S, Wang N, Zhu Y, Tang J, Gu L, Yang J, Cheng C, Chen J, Kuai W, Lu X, Shao J, Xie Z, Lu J, Leung W, Li B, Pui CH. · JAMA Oncol · 2026 · cited 0 timescomment, clinical trial, phase ii
- Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932.
Rodwin RL, Kairalla JA, Hibbitts E, Balsamo LM, Devidas M, Mossman B, Dreyzin A, Winick NJ, Sung L, Conley C, Carroll WL, Hunger SP, Raetz E, Ness KK, Loh ML, Schore RJ, Angiolillo AL, Kadan-Lottick NS. · J Natl Compr Canc Netw · 2026 · cited 0 timesmulticenter study, randomized controlled trial
- Online Physical Activity and Health Counseling for Survivors of Childhood Acute Lymphoblastic Leukemia (OPAC-ALL)- a study protocol.
Fridh MK, Hansen MB, Pouplier A, Schmidt-Andersen P, Andrés-Jensen L, Müller K, Christensen J, Ness KK, Ha L, Larsen HB. · BMC Cancer · 2026 · cited 0 timesclinical trial protocol
- Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.
Jabbour E, Rausch CR, Goulart H, Jain N, Ravandi F, Maiti A, Alvarado Y, Burger J, Yilmaz M, Khouri I, Kebriaei P, Jorgensen J, Wang SA, Wang X, Mayor E, Garris RS, Short NJ, Kantarjian H. · Blood Cancer J · 2026 · cited 1 timesOpen accessclinical trial, phase ii
- Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial.
Zhang L, Wang C, Patil S, Luo Y, Liu X, Long X, Yin Y. · Support Care Cancer · 2026 · cited 0 timesrandomized controlled trial
- Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
Fatima F, Jha A, Raza A, Aslam F, Mirza A, Cheema U, Javaid H, Cheema S, Qureshi Z. · Am J Clin Oncol · 2026 · cited 0 timesmeta-analysis, systematic review
- Frontline therapies for adult patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia: a systematic literature review.
Meza MV, Hodgkinson S, Eichinger CS, Zaman F, Boyko D. · Hematology · 2026 · cited 0 timessystematic review
- Efficacy of fluoroquinolone prophylaxis during induction phase in children with acute lymphoblastic leukemia: a systematic review and meta-analysis.
Landivar MC, Hartmann Rost I, Carvalho Kilson A, Torres Campo MA, Santarosa Vieira AG. · Eur J Pediatr · 2026 · cited 0 timesmeta-analysis, systematic review
- Prioritized health outcomes for adolescents and young adults with acute lymphoblastic leukemia.
Saldanha IJ, Sereda Y, Kanaan G, Mai HJ, Melson JW, Terasawa T, Gupta S, O'Dwyer KM, Wolfson JA, Stock W, Cheung MC, Balk EM. · Blood Neoplasia · 2026 · cited 3 timesOpen accessclinical trial
- A systematic review of machine and deep learning techniques for acute lymphoblastic leukemia diagnosis.
Shah WH, Fatima SR, Jaimes-Reátegui R, Arévalo-Simental DE, Villalobos-Gutiérrez PT, Pisarchik AN. · Artif Intell Med · 2026 · cited 0 timessystematic review
- A Mobile Health Intervention to Reduce Sedentary Behavior Among Adolescents and Early Young Adults Receiving Treatment for Acute Lymphoblastic Leukemia: Protocol for a Single-Arm Feasibility Trial.
Ivory BJ, Chi YY, Belcher BR, Freyer DR. · JMIR Res Protoc · 2026 · cited 0 timesOpen accessclinical trial protocol
- CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis.
Navarro V, Iacoboni G, Camarillas S, Carpio C, Sánchez-Salinas M, Feijoo S, Bosch F, Villacampa G, Barba P. · Bone Marrow Transplant · 2026 · cited 2 timesmeta-analysis, systematic review
- Clinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.
Shah BD, Iloabuchi C, Harrigan S, Ray M, Santaolalla Revenga A, Cobley D, Nissen F, Kanters S, Oluwole OO. · J Manag Care Spec Pharm · 2026 · cited 0 timesmeta-analysis, systematic review
- Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.
Boissel N, Huguet F, Leguay T, Hunault M, Kim R, Hicheri Y, Passet M, Chevallier P, Balsat M, Pastoret C, Delabesse E, Maury S, Thiebaut-Bertrand A, Van Obbergh F, Cluzeau T, Escoffre-Barbe M, Straetmans N, Konopacki J, Belhabri A, Villate A, Pasquier F, Vaida I, Sanhes L, Blum S, Alexis M, Lamarque M, Farnault L, Berthon C, Lhéritier V, Ifrah N, Graux C, Chalandon Y, Clappier E, Dombret H. · Blood · 2026 · cited 3 timesclinical trial, phase ii, multicenter study
- The Pharmacokinetics and Relative Bioavailability of a Mini-Tablet of Mercaptopurine, a Novel Formulation for Use in Children with Acute Lymphoblastic Leukemia.
Chen Z, Zheng YY, Liu QL, Ye PP, Yang XM, Song LL, Chen KG, Zhao FR, Shi JY, Zhang YH, Zhou HY, van den Anker J, Yang Y, Zhao Q, Li Q, Lu WC, Zhou Y, Zhao W. · J Clin Pharmacol · 2026 · cited 0 timesrandomized controlled trial
- Association Between Maternal Infection During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia in Offspring: A Systematic Review and Meta-Analysis.
Chen X, Wang S, Yu W, Liu M, Cai J, Wang H. · Pediatr Blood Cancer · 2026 · cited 0 timesmeta-analysis, systematic review
- Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Topp MS, Shah BD, Jabbour E, Park JH, Shaughnessy P, Logan AC, Sandhu KS, Abedi M, Bishop MR, DeAngelo DJ, Yin X, Davi R, Hodby K, Malladi R, Brugger W, Shang J, Roddie C, Kantarjian HM. · Leukemia · 2026 · cited 0 timesOpen accessclinical trial, phase ii, comparative study
- Transcriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy.
Wang S, Liu W, Wang Y, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Qiu S, Wei H, Gu R, Wang M, Wang J. · Cancer Med · 2026 · cited 0 timesOpen accessclinical trial, phase ii
- Targeted therapies in pediatric B-Cell acute lymphoblastic leukemia: mechanisms, efficacy, and future directions.
Correa-Carranza V, Rosario-Méndez G, Castillejos-López M, Chávez-Pacheco JL, Galván-Díaz C, Torres-Espíndola LM. · Front Pharmacol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.